Abstract:Objective: To study the effect of plumbagin on epithelial-mesenchymal transition (EMT) and underlying mechanisms in human tongue squamous cell carcinoma (TSCC) cells. Methods: Methyl thiazolyl tetrazolium assay was apllied to examine the proliferation inhibition effect and half maximal inhibitory concentration (IC(50)) of plumbagin (0.1, 1.0, 5.0, 10.0, 20.0 μmol/L) in 12, 24, 48 h in TSCC cells. Transwell assay was used to count the number of transmembrane cells and scratch test was performed to examine cells mobility. The flow cytometry was applied to measure intracellular reactive oxygen species (ROS) level in control group, plumbagin group (1.0 μmol/L, 24 h) and glutathione (GSH)+plumbagin group. The expression of E-cadherin, vimentin, Slug, p38 mitogen activated protein kinases (p38MAPK) and phospho-p38MAPK (p-p38MAPK) proteins were determined by Western blotting. The expression of E-cadherin, vimentin and Slug were detected by Western blotting in control group, plumbagin group, activator combined group (p38MAPK activator+plumbagin) and inhibitor combined group (p38MAPK inhibitor+plumbagin). Results: After the treatment of plumbagin for 12, 24, and 48 h, the IC(50) of TSCC cells were 10.3, 3.1, 1.5 μmol/L. After treated by 1.0 μmol/L plumbagin for 24 h, the number of transmembrane cells were significantly reduced ([50±13], P<0.05) in comparison to control group (204±6), as well as the cells mobility ([18.2±2.3]%, P<0.05) in comparison to control group ([49.3±1.2]%). Compared to control group (2.32±0.52), the ROS level was increased in plumbagin group (902.20±10.69), while compared to plumbagin group, the ROS level was reduced in GSH combined group (2.18±0.15). In comparison to control group, the expression of E-cadherin was up-regulated (P<0.05), and vimentin, Slug, p-p38MAPK/p38MAPK were down-regulated in plumbagin group (P<0.05). In comparison to plumbagin group, the expression of E-cadherin was down-regulated (P<0.05), and vimentin, Slug, p-p38MAPK/p38MAPK were up-regulated in GSH combined group (P<0.05). Treatment of cells with p38MAPK activator could decrease the expression of E-cadherin significantly (P<0.05) and increase the expression of vimentin (P<0.05) and Slug (P<0.05) in comparison to plumbagin group. Treatment of cells with p38MAPK inhibitor could increase the expression of E-cadherin significantly (P<0.05) and decrease the expression of vimentin (P<0.05) and Slug (P<0.05) in comparison to plumbagin group. Conclusions: Plumbagin inhibits EMT via ROS/p38MAPK-mediated pathway in human TSCC cells.

Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions

Research of the inhibitory effect and the mechanisms of plumbagin on large cell lung cancer NL9980 cell line

Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition

Plumbagin Shows Anti-Cancer Activity in Human Breast Cancer Cells by the Upregulation of P53 and P21 and Suppression of G1 Cell Cycle Regulators

Research on the anti-tumor effect of Plumbagin against human highly metastatic large cell lung cancer cell line

Effects of Plumbagin on the Human Breast Cancer Cell Mda-Mb-231 in Vitro

Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Suppressing the Migration and Invasion of Tumor-Derived Vascular Endothelial Cells

Dddt_a_200610 1289..1300

Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2

Correction To: Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-Regulation of Inflammatory Cytokine Expressions

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA

Plumbagin, a Medicinal Plant (lumbago Zeylanica)‐derived 1,4‐naphthoquinone, Inhibits Growth and Metastasis of Human Prostate Cancer PC‐3M‐luciferase Cells in an Orthotopic Xenograft Mouse Model

Effects of Plumbagin on the Level of IL-2 and TNF-α in Tumor-Bearing Mice

Plumbagin Promotes Human Hepatoma SMMC-7721 Cell Apoptosis Via Caspase-3/Vimentin Signal-Mediated EMT

Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro.

Plumbagin Suppresses Epithelial to Mesenchymal Transition and Stemness Via Inhibiting Nrf2-mediated Signaling Pathway in Human Tongue Squamous Cell Carcinoma Cells.

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

Plumbagin Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR-mediated Pathway in Human Pancreatic Cancer Cells

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

Plumbagin from Plumbago Zeylanica L Induces Apoptosis in Human Non-small Cell Lung Cancer Cell Lines Through NF-κB Inactivation

[Effect of Plumbagin on Epithelial-Mesenchymal Transition and Underlying Mechanisms in Human Tongue Squamous Cell Carcinoma Cells].